US Broker Ratings

Thermo Fisher Scientific Inc (TMO) Stock Analysis: Exploring a 27.67% Potential Upside

Thermo Fisher Scientific Inc (NYSE: TMO), a titan in the healthcare sector, particularly in diagnostics and research, stands as a compelling investment opportunity for those seeking exposure to the life..

Align Technology, Inc. (ALGN) Stock Analysis: Exploring a 19.58% Upside Potential

Align Technology, Inc. (NASDAQ: ALGN), a key player in the healthcare sector under the medical instruments and supplies industry, is renowned for its innovative Invisalign clear aligners and iTero intraoral..

Dr. Reddy’s Laboratories Ltd (RDY) Stock Analysis: Valuation Insights and Growth Potential

Dr. Reddy’s Laboratories Ltd (NYSE: RDY), a prominent player in the healthcare sector, stands as a formidable entity within the drug manufacturing industry, particularly in the specialty and generic categories...

Elevance Health, Inc. (ELV) Stock Analysis: Navigating the Healthcare Giant’s Growth Potential

Elevance Health, Inc. (NYSE: ELV), formerly known as Anthem, Inc., is a pivotal player in the healthcare plans industry in the United States, with a substantial market capitalization of $87.75..

Haleon plc (HLN) Stock Analysis: Exploring a 28.59% Potential Upside in the Healthcare Sector

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, has been capturing investor attention with its robust market presence and significant potential upside. Specializing in consumer healthcare products,..

AptarGroup, Inc. (ATR) Stock Analysis: Evaluating a 36% Potential Upside in Medical Instruments

AptarGroup, Inc. (NYSE: ATR), a key player in the medical instruments and supplies industry, is capturing investor attention with its promising 36.28% potential upside. With a strong foothold in the..

Waters Corporation (WAT) Investor Outlook: Analyzing a 12.58% Potential Upside

Waters Corporation (NYSE: WAT), a prominent player in the healthcare sector, stands at a compelling juncture for investors seeking opportunities in the diagnostics and research industry. With a significant market..

Becton, Dickinson and Company (BDX): Investor Outlook with a 23.56% Potential Upside

As individual investors seek promising opportunities within the healthcare sector, Becton, Dickinson and Company (NYSE: BDX) stands out with a compelling narrative driven by its substantive market presence and potential..

Illumina, Inc. (ILMN): Investor Outlook on a Genomic Pioneer with a 33.82% ROE

Illumina, Inc. (NASDAQ: ILMN) stands as a prominent player in the healthcare sector, specifically within the diagnostics and research industry. Known for its sequencing and array-based solutions, Illumina provides essential..

Cencora, Inc. (COR) Stock Analysis: Exploring a 24% Potential Upside in Healthcare Distribution

Cencora, Inc. (NYSE: COR), a prominent player in the healthcare distribution industry, stands out with a compelling market cap of $54.8 billion. The company, formerly known as AmerisourceBergen Corporation, has..

Regeneron Pharmaceuticals, Inc. (REGN)

⚠️ No article content returned.

..

Zimmer Biomet Holdings, Inc. (ZBH) Stock Analysis: Potential 11.44% Upside Amid Robust Revenue Growth

Zimmer Biomet Holdings, Inc. (NYSE: ZBH) stands as a pivotal player in the healthcare sector, particularly within the medical devices industry. With a market capitalization of $17.13 billion, the company..

Pfizer, Inc. (PFE)

⚠️ No article content returned.

..

Incyte Corporation (INCY) Stock Analysis: A Biotech Innovator with a Robust Revenue Growth and Promising Pipeline

Incyte Corporation (NASDAQ: INCY), a prominent player in the biotechnology sector, has been making waves with its innovative approach to therapeutic development. With a market capitalization of $21.68 billion, Incyte..

Koninklijke Philips N.V. (PHG) Stock Analysis: Navigating Market Pressures with a 26.76% Potential Upside

Koninklijke Philips N.V. (NYSE: PHG), a titan in the healthcare sector, is experiencing a dynamic phase marked by significant market fluctuations and strategic pivots. With a market capitalization of $25.72..

The Cooper Companies, Inc. (COO): Investor Outlook with an 18.70% Potential Upside

The Cooper Companies, Inc. (NYSE: COO), a prominent player in the healthcare sector, is drawing investor interest with its robust potential upside of 18.70%, as highlighted by recent analyst ratings...

Agilent Technologies, Inc. (A) Stock Analysis: 23.5% Potential Upside and Strong Buy Ratings Propel Investor Interest

Agilent Technologies, Inc. (NYSE: A), a prominent player in the healthcare sector’s diagnostics and research industry, is capturing investor attention with its promising potential upside and robust market performance. With..

CVS Health Corporation (CVS) Stock Analysis: Navigating a 2.49% Potential Upside Amid Solid Buy Ratings

For investors with a keen eye on the healthcare sector, CVS Health Corporation (NYSE: CVS) presents a compelling opportunity. With a market capitalization of $130.09 billion, CVS stands as a..

UnitedHealth Group (UNH) Stock Analysis: Navigating Growth Amidst a Stable Dividend Yield

UnitedHealth Group Incorporated (NYSE: UNH) stands out as a formidable player in the healthcare sector, with a commanding market capitalization of $371 billion. Operating primarily in the United States, UnitedHealth..

IQVIA Holdings, Inc. (IQV) Stock Analysis: Exploring a Potential 25% Upside in Healthcare Innovation

Investors keeping a close watch on IQVIA Holdings, Inc. (NYSE: IQV) might find it hard to overlook the significant potential upside of 25.07% suggested by the stock’s current analysis. Situated..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds